# DongGuk University

Organization · id `cardio:org-dongguk-university` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 057q6n778](<https://ror.org/057q6n778>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 057q6n778 by an exact name.

## The registry's words

- Sponsor name: DongGuk University
- Sponsor class: OTHER
- ROR name: Dongguk University

## Connected pages

- Sponsors: A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy (`cardio:ct-nct01258673`)
- Sponsors: A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension (`cardio:ct-nct01518998`)
- Sponsors: Fimasartan/Amlodipine Combination Phase III (`cardio:ct-nct02152306`)

## Provenance

Content hash: 9b8b26145b838931fad0ab02d02a5409fe085831a03ee3cfeb4190df2ff29677
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
